Emergingby GlyphChai Discovery raises $400M at a $3.8B valuation
Investors include Index Ventures, Kleiner Perkins, Sequoia Capital and Dimension.
Synthetic biologychaidiscovery.com
Chai Discovery
StartupUS1 field
Where it works
| Technology | ||
|---|---|---|
| Synthetic biologyBuilds foundation models such as Chai-2 for de novo antibody and molecule design. | Builds foundation models such as Chai-2 for de novo antibody and molecule design. | chaidiscovery.com |
Events
Chai Discovery releases Chai-2 for zero-shot antibody design
Chai-2 reported double digit hit rates in de novo antibody design.
Synthetic biologychaidiscovery.com
Funding
About
- Source
- chaidiscovery.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Oct 6, 2026
- Across Glyph
- Chai Discovery on Companies
Chai Discovery
Joined in Synthetic biology. Builds foundation models such as Chai-2 for de novo antibody and molecule design.
Chai Discovery
Added in Synthetic biology. Builds foundation models such as Chai-2 for de novo antibody and molecule design.